Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2008
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1685105B1 Allosteric modulators of metabotropic glutamate receptors
10/15/2008EP1660455B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/15/2008EP1587585B1 Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases
10/15/2008EP1569901B1 ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
10/15/2008EP1537081B1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
10/15/2008EP1532158B1 Neutral metallic dendrimer complexes
10/15/2008EP1444202B1 Novel metalloproteinase inhibitors
10/15/2008EP1411940B1 Bridged piperidine derivatives as melanocortin receptor agonists
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
10/15/2008EP1173432B9 Piperidine-indole compounds having 5-ht6 affinity
10/15/2008EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/15/2008CN101287729A GPCR agonists
10/15/2008CN101287727A Novel high affinity quinoline-based kinase ligands
10/15/2008CN101287726A Pyrrolidine and piperidine acetylene derivatives for use as MGLUR5 antagonists
10/15/2008CN101287723A Amide alkyl pyridiyl quinolines as nk3 receptor modulators
10/15/2008CN101287722A Substituted piperazines as metabotropic glutamate receptor antagonists
10/15/2008CN101287721A 酰肼化合物和其杀虫用途 Hydrazide compounds and their insecticidal use
10/15/2008CN101287715A Amide derivatives
10/15/2008CN101287707A 激酶抑制剂 Kinase inhibitors
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN101284828A Cycloheptapyridine compounds, preparation method thereof, use and pharmaceutical compositions containing the compounds
10/15/2008CN101284827A Antineoplastic compounds containing triazole ring naphthoyl imines and method for preparing same
10/15/2008CN101284819A Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
10/15/2008CN100425607C Method for controlling particular insects by applying anthranilamide compounds
10/14/2008US7436570 Electrochromic salts, solutions, and devices
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008US7435826 Esomeprazole intermediates: 1-(S or R)-camphorsulfonyl-2-(2-pyridylmethylsulfinyl)-1H-benzimidazole and derivatives, e.g., 1-(S)-camphor sulfonyl-5-methoxy-2-[(3,5-dimethyl-4-methoxy-2-pyridyl)methyl-(S)-sulfinyl]-1H-benzimidazole
10/14/2008US7435825 Crystals of benzimidizoles formed by isolation of base and water soluble base
10/14/2008US7435824 Prodrugs of potassium channel inhibitors
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008US7435822 Delta and mu opioid receptors modulators, agonist or antagonist; analgesics, immunosuppressants, antiinflammatory agents; 3-(Phenyl-thiophen-3-yl-methylene)-8-aza-bicyclo[3.2.1]octane; ; neurological and psychiatric conditions; drug and alcohol abuse,; gastritis; diarrhea; cardiovascular; respiratory
10/14/2008US7435815 Sulfonylamino-acetic acid derivatives
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435753 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; Coupling of an aryldiazonium salt with a 2,3-dicyano-3-cyclopropyl propanoate; parasiticides; fleas; Extended duration of action for at least 28 days
10/14/2008US7435747 Guanidine and amidine derivatives as factor Xa inhibitors
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435736 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders
10/14/2008US7435734 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008US7435728 Pyrazole derivatives
10/14/2008CA2384331C The use of halofuginone and related compounds for the treatment of urethral stricture by local administration
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2222138C Method of preparing 3-haloalkyl-1h-pyrazoles
10/09/2008WO2008121861A2 Pyrazole and pyrrole compounds useful in treating iron disorders
10/09/2008WO2008121686A1 Sub-type selective azabicycloalkane derivatives
10/09/2008WO2008121066A1 Novel tricyclic spiropiperidines or spiropyrrolidines and their use as modulators of chemokine receptors
10/09/2008WO2008121065A1 Novel pyrrolidine derivatives as antagonists of the chemokine receptor
10/09/2008WO2008120992A1 Novel antibiotics
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120759A1 Urea compound and use thereof
10/09/2008WO2008120754A1 Picolinamide compound
10/09/2008WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same
10/09/2008WO2008120661A1 Novel fused pyrrole derivative
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008119825A2 Imidazolidine carboxamide derivatives as p2x7 modulators
10/09/2008WO2008119759A1 Acetone solvate of phthaloyl amlodipine
10/09/2008WO2008119721A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119720A1 1-(1-cyclobutyl-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119719A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119717A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119716A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119715A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008119694A1 Benzimidazole cannabinoid agonists
10/09/2008WO2008119689A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/09/2008WO2008119657A1 Imidazolidinone derivatives
10/09/2008WO2008119569A1 Synthesis of anthranilamides
10/09/2008WO2008101682A3 Iminipyridine derivatives and their uses as microbiocides
10/09/2008WO2008092942A3 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators
10/09/2008WO2008062276A8 Acetylene derivatives as stearoyl coa desaturase inhibitors
10/09/2008WO2008054454A3 Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
10/09/2008WO2008016811A3 Aminopiperidines and realted compounds
10/09/2008WO2008002244A8 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
10/09/2008WO2007149478A3 Pyrazine derivatives with extended conjugation and uses thereof
10/09/2008WO2007107706A3 Dimers of heterocyclic compounds for the treatment of copd
10/09/2008US20080249303 contacting a drug mixture with an extraction medium to produce a suspension, then filtering and drying the residue, to obtain 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol acetic acid, free of components that produce X-Ray diffraction patterns having interfering peaks
10/09/2008US20080249301 Regioselective Process for Preparing Benzimidazole Thiophenes
10/09/2008US20080249135 Compounds for alzheimer's disease
10/09/2008US20080249131 treatment of HIV; N-(2-Bromo-4-methylphenyl)-2-(5-methyl-4-phenyl-4H-[1,2,4]triazole-3-ylsulfanyl)-acetamide
10/09/2008US20080249128 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
10/09/2008US20080249121 Condensing (3-trifluoromethylsulfonyl) benzoyl chloride and 4-methyl-2-nitro-aniline; reducing nitro group with stannous chloride; condensing amino group with cyanamide; cyclocondensing guanidine group with 3-dimethylamino-1-pyridin-3-yl-propenone; antiproliferative agent
10/09/2008US20080249114 Beta-3 adrenergic receptor agonists; urinary tract infections, incontinence, gastrointestinal disorders, dysmenorrhea, obesity; tocolytic, anxiolytic, antidiabetic agents; antidepressants; 4-(2-hydroxy-3-(1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol
10/09/2008US20080249111 Piperdine Derivatives as CCR5 Inhibitors
10/09/2008US20080249110 Novel Substituted 3-Sulfur Indoles
10/09/2008US20080249108 treatment of sleep disorders or inflammatory diseases of the bladder by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide methansulfonate
10/09/2008US20080249106 3-(1-((R)-7-((4-fluoropiperidin-1-yl)methyl)-3,4-dihydro-2H-chromen-4-yl)-1H-1,2,3-triazol-4-yl)-2-(4-methylphenylsulfonamido)propanoic acid; chronic pain analgesics; side effect reduction
10/09/2008US20080249105 And Erectile Dysfunction; rho kinase inhibitors; [3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]amine
10/09/2008US20080249104 Salt Forms of 4- (4-Methylpiperazin-1-Ylmethyl) -N- [4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl]- Benzamide
10/09/2008US20080249099 7-Phenylalkyl Substituted 2-Quinolinones and 2-Quinoxalinones as Poly(Adp-Ribose) Polymerase Inhibitors
10/09/2008US20080249092 3-(phenylsulfonyl)-N-(tetrahydro-2H-pyran-4-ylmethyl)-8-quinolinamine; selectively modulating the cannabinoid 2 receptor; treatment of CNS disorders
10/09/2008US20080249091 Indoles Useful in the Treatment of Inflammation
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008US20080249081 Compounds for the treatment of pain and screening methods therefor
10/09/2008US20080248956 For liquid environments like pools, ponds, fish farms, lakes, streams, paddies, rivers, oceans, estuaries, freshwater aquariums, salt water aquariums, aquacultures, tanks for commercial aquaculture, ponds for commercial aquaculture, ornamental ponds
1 ... 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 ... 1080